Procter & Gamble Non-GAAP EPS of $2.00 beats by $0.11, revenue of $23.28B beats by $460M (PG:NYSE)

Procter & Gamble reported non-GAAP EPS of $2.00, beating estimates by $0.11, with revenue of $23.28B, exceeding expectations by $460M. The company anticipates $1.9B in headwinds, reducing EPS by $0.79 in fiscal 2027. P&G projects 2-4% sales growth and core EPS growth of in-line to 3%, with a mid-point core EPS target of $7.00. It plans $4.5-5.5% of net sales for capital spending, over $10B in dividends, and $5B in share repurchases.

Original reporting
Published Oct 22, 2026, 11:02 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PG
Bullish
high confidence
Mentioned
$PG
Relevance
9/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$PGBullishHigh
01

Why it matters

The guidance suggests modest growth but highlights significant cost pressures, which may lead to a cautious market reaction.

02

Market read

P&G's guidance is material for the S&P 500 and consumer‑staples sector, influencing short‑term price action and analyst outlooks.

03

What to watch

Potential cost‑saving initiatives or pricing power in core brands could mitigate the projected headwinds.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

The article provides P&G's latest earnings beat and forward guidance, a key data point for investors tracking consumer‑staples performance.

Company-level read

Ticker impact

$PGBullishHigh confidence
Context

Procter & Gamble reported non‑GAAP EPS of $2.00 beating estimates and gave FY2027 guidance on sales growth, EPS and capital allocation.

Expected impact

likely modest pressure as investors price in the EPS drag from commodity and interest‑rate headwinds

Evidence & confidence

The beat on EPS is positive, but the detailed guidance highlights significant cost pressures that could limit share price gains.

Market effects

Consumer staples may see similar headwinds from commodity price inflation, prompting analysts to reassess sector earnings forecasts.

U.S. large‑cap indices could face slight downside pressure as P&G is a major component of the S&P 500.

Global consumer‑goods makers may be impacted by the same commodity and interest‑rate environment highlighted by P&G.

Counterpoint

Despite the EPS drag, the $10 B dividend payout and $5 B share repurchase could support the stock if cash flow remains strong.

Key entities

  • Procter & Gamble

    U.S. consumer‑staples giant reporting earnings and FY2027 guidance.

Related articles

$PGMed

P&G Plans To Cut Up To 30% Product Supply Jobs By 2030; Confirms FY27 Outlook

Procter & Gamble (P&G) plans to cut 20-30% of product supply jobs by 2030, aiming for $10B in productivity savings. The company maintained its FY27 outlook, projecting 2-4% net sales growth and 1-3% organic sales growth. P&G also expects $1.8B in annual productivity savings and $30B in growth opportunities. Shares gained 0.30% to $168.35 in overnight trading.

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November